Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.
Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.
Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.
Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.
Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.
Canopy Growth Corporation will transfer its U.S. stock listing from the New York Stock Exchange to the Nasdaq effective November 13, 2020. This transition aims to enhance cost-effectiveness and improve investor connectivity. Common shares will start trading on Nasdaq under the ticker CGC on November 16, 2020, with no action required from current shareholders. CEO David Klein emphasized the move aligns Canopy with leading innovative companies. The company is known for its diversified cannabis products and has significant partnerships in the industry.
Canopy Growth Corporation (TSX: WEED, NYSE: CGC) will announce its financial results for the second quarter of fiscal 2021, concluding on September 30, 2020, before markets open on November 9, 2020. Following the results, CEO David Klein and CFO Mike Lee will host an audio webcast at 10:00 AM ET. Canopy Growth continues to lead in the cannabis industry with its diversified product offerings and strong brand presence across Canada, including Tweed and Tokyo Smoke.
Canopy Growth Corporation (CGC) and Acreage Holdings have partnered to introduce Canopy's THC beverages in the U.S., starting summer 2021. Acreage aims to leverage its presence in Illinois and California to market these products through both its own dispensaries and existing distribution channels. Canopy has achieved significant success in Canada, selling over 1.7 million cans and holding a 74% market share in the cannabis beverage sector. The collaboration aims to capture growth in the expanding U.S. cannabis market.
Canopy Growth Corporation (NYSE: CGC) and Acreage Holdings, Inc. have executed an amended arrangement under British Columbia law. The arrangement introduces new share classes, allowing for the exchange of existing shares into Fixed and Floating Shares. Trading of these shares begins today on the Canadian Securities Exchange. Canopy Growth will acquire Fixed Shares at a specified exchange rate once U.S. federal marijuana laws permit. Acreage will remain independent while focusing on profitability and expanding its product offerings. Shareholders are set to receive approximately $0.30 per share as part of a $37.5 million upfront payment.
Canopy Growth announced the results from its annual general and special meeting of shareholders held on September 21, 2020. A total of 260,647,934 common shares were voted, representing 70.22% of outstanding shares. All proposed matters, including the election of directors and appointment of KPMG as auditors for fiscal 2021, were approved. Directors Judy A. Schmeling and David Klein received 99.13% and 99.05% approval, respectively. Shareholders also greenlit amendments to the Omnibus Incentive Plan and established annual votes on executive compensation.
Canopy Growth Corporation and Acreage Holdings announced that Acreage received final court approval for an amended arrangement under British Columbia law. The implementation is expected around September 23, 2020. Eligible Acreage shareholders as of September 22 will receive a pro rata share of US$37,500,024, approximately US$0.30 per Subordinate Voting Share. Shareholder approval was granted on September 16, 2020. This arrangement may lead to wider operational collaboration and potential for growth in the cannabis sector.
Canopy Growth Corporation (NYSE: CGC) has launched Martha Stewart CBD, a premium line of hemp-derived wellness products created in collaboration with Martha Stewart. This new offering includes gourmet flavored wellness gummies, softgels, and oil drops, aiming to provide consumers with high-quality, scientifically formulated CBD supplements. The initial product lineup features items priced between $34.99 and $44.99, designed to support daily wellness routines. These products are available for purchase online at Canopy Growth's ecommerce platform.
Canopy Growth announced that CEO David Klein and EVP & CFO Mike Lee will speak at the Barclays Global Consumer Staples Conference on September 9, 2020, at 4:40 PM ET. The event will be available via live audio webcast on Canopy Growth's website, with a replay option for later access. Canopy Growth is a leading cannabis and hemp product company known for its brands and innovative market strategies. It operates retail stores in Canada and has partnerships with notable figures like Snoop Dogg and Martha Stewart.
Canopy Growth Corporation (NYSE: CGC) will host its 2020 Annual General and Special Meeting on September 21, 2020, starting at 10:00 AM ET. The meeting will occur in a virtual format accessible via a live audio webcast. Shareholders of record as of July 28, 2020 are eligible to vote. A notice detailing instructions on how to participate and vote has been mailed to eligible shareholders. Canopy Growth is a leading cannabis company known for its diverse products and significant market presence, including partnerships with notable brands.
Canopy Growth Corporation reported a 22% increase in net revenue to $110.4 million for Q1 FY21 compared to Q1 FY20, despite a net loss of $128.3 million. The Adjusted EBITDA loss narrowed to $92 million. The company strengthened its position in the cannabis-infused beverage market by shipping over 1.2 million cans since launch and expanded its U.S. presence with the launch of shopcanopy.com. Gross margins fell to 6%, affected by lower production output. The company reduced operating expenses by 23% and maintained a strong cash position of $2 billion.